Skip to main content

Table 1 Demographic data and clinical presentations of the enrolled UC and IBS patients

From: Evaluation of the diagnostic performance of estimated fecal calprotectin and serum intelectin-1 and C-reactive protein solo or in combination for differentiation between patients with query ulcerative colitis and irritable bowel syndrome

Data

UC (n = 51)

IBS (n = 291)

p-value

Age (years)

Age strata

 < 2 5

2 (3.9%)

11 (3.8%)

0.005

25–30

10 (19.6%)

88 (30.2%)

31–40

14 (27.5%)

117 (40.2%)

41–50

23 (45.1%)

55 (18.9%)

 > 50

2 (3.9%)

20 (6.9%)

Average (± SD)

39 (± 8.7)

35.5 (± 8)

0.0018

Gender

Males

16 (31.4%)

85 (29.2%)

0.755

Females

35 (68.6%)

206 (70.8%)

BMI (kg/m2)

Strata

 < 25

0

4 (1.4%)

0.265

25–30

9 (17.6%)

77 (26.5%)

 > 30–35

42 (82.4%)

210 (72.1%)

Average (± SD)

31.5 (± 1.88)

31.2 (± 2.8)

0.312

Smoking

Smoker

13 (25.5%)

69 (23.7%)

0.648

Ex-smoker

9 (17.6%)

39 (13.4%)

Un-smoker

29 (56.9%)

183 (62.9%)

Clinical presentation

Recurrent abdominal pain

39 (76.5%)

291 (100%)

 < 0.001

Bowel habit

Diarrhea

43 (84.3%)

63 (14.4%)

 < 0.001

Constipation

0

42 (14.4%)

 

Alternating

0

49 (16.8%)

 

Uncategorized

0

137 (47.1%)

 

Hematochezia

32 (62.7%)

20 (6.9%)

 < 0.001

Pus in stool

26 (51%)

33 (11.3%)

 < 0.001